Stockholm - Free Realtime Quote SEK

SynAct Pharma AB (SYNACT.ST)

17.96
-0.76
(-4.06%)
As of 10:32:44 AM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expense
92,059
89,668
149,840
105,573
76,715
Operating Income
-92,059
-89,668
-149,840
-105,573
-76,715
Net Non Operating Interest Income Expense
-2,475
-590
-204
-247
-105
Pretax Income
-95,100
-90,824
-224,275
-107,066
-76,809
Tax Provision
-12,922
-8,424
-8,466
-7,860
-7,505
Net Income Common Stockholders
-82,179
-82,401
-215,810
-99,205
-69,304
Diluted NI Available to Com Stockholders
-82,179
-82,401
-215,810
-99,205
-69,304
Basic EPS
-1.89
-2.08
-6.64
-3.57
-2.66
Diluted EPS
-1.89
-2.08
-6.64
-3.57
-2.66
Basic Average Shares
7,214.77
3,953.27
32,523.86
27,836.19
26,083.87
Diluted Average Shares
7,214.77
3,953.27
32,523.86
27,836.19
26,083.87
Total Operating Income as Reported
--
-89,980
-224,496
-105,705
-76,699
Total Expenses
92,059
89,668
149,840
105,573
76,715
Net Income from Continuing & Discontinued Operation
-82,179
-82,401
-215,810
-99,205
-69,304
Normalized Income
-82,179
-82,401
-69,508.44
-99,205
-69,304
Interest Income
--
230
593
47
0
Interest Expense
--
820
797
294
105
Net Interest Income
-2,475
-590
-204
-247
-105
EBIT
-92,395
-90,004
-223,478
-106,772
-76,704
EBITDA
-92,395
-89,390
-148,142
-105,754
-76,616
Reconciled Depreciation
--
614
75,336
1,018
88
Net Income from Continuing Operation Net Minority Interest
-82,179
-82,401
-215,810
-99,205
-69,304
Total Unusual Items Excluding Goodwill
0
0
-74,558
0
--
Total Unusual Items
0
0
0
0
--
Normalized EBITDA
-92,395
-89,390
-148,142
-105,754
-76,616
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
-2,814.44
0
0
12/31/2021 - 7/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELIC.ST Elicera Therapeutics AB (publ)
5.97
-3.40%
 
ATORX.ST Alligator Bioscience AB (publ)
3.8480
-1.33%
 
SPRINT.ST Sprint Bioscience AB (publ)
0.4170
-0.24%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0990
-0.40%
 
XINT.ST Xintela AB (publ)
0.4940
+7.63%
 
ACE.ST Ascelia Pharma AB (publ)
4.9500
+1.96%
 
FLUI.ST Fluicell AB (publ)
11.90
+3.48%
 
ALZ.ST Alzinova AB (publ)
1.6160
+2.28%
 
XSPRAY.ST Xspray Pharma AB (publ)
30.50
-2.56%
 
KAN.ST Kancera AB (publ)
1.1500
+1.41%